Hormone implant aimed at saving uteruses after failed ablation – trial pulled
Disease control
Terminated
This study planned to test whether an etonogestrel implant (Nexplanon) could reduce the need for hysterectomy in women who still had abnormal bleeding or pelvic pain after endometrial ablation. The trial was withdrawn before enrolling any participants, so no data were collected. …
Phase: PHASE2 • Sponsor: Saskatchewan Health Authority - Regina Area • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC